Navigation Links
FDA Lifts Injunction on Manufacture and Sale of CareFusion Alaris(R) SE Pump
Date:1/11/2010

SAN DIEGO, Jan. 11 /PRNewswire-FirstCall/ -- CareFusion (NYSE: CFN), a leading, global medical device company, announced today that the Food and Drug Administration (FDA) has given the company permission to resume manufacturing and marketing the Alaris® SE line of infusion pumps (also known as the Signature Edition® infusion pump).

CareFusion, formerly the Clinical and Medical Products division of Cardinal Health, has been operating under a consent decree with the FDA since February 2007. The consent decree included an injunction on the manufacture and sale of the Alaris SE pump. The FDA recently notified CareFusion that the injunction has been lifted, allowing the company to resume sales of the Alaris SE pump.

"We have worked diligently over the past several years to improve our quality system and to complete the necessary steps to resume the production, sale and installation of the Alaris SE pump," said David Schlotterbeck, chairman and CEO of CareFusion. "While we still have work to do under our consent decree, we are pleased to have reached this important milestone."

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and Pulmonetic Systems ventilation and respiratory products, ChloraPrep® products, MedMined(TM) services for infection surveillance, NeuroCare neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.

SOURCE CareFusion Corporation

RELATED LINKS
http://www.carefusion.com

'/>"/>

SOURCE CareFusion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Lifts Clinical Hold on Gentas Tesetaxel, a Leading Oral Taxane
2. New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties
3. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
4. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
5. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
6. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
7. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
8. QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR
9. Eclipse Announces Partnership with Human Med USA, Manufacturers of Revolutionary Body-Jet(R)
10. Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand
11. China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... , July 13, 2017 It should come ... States is in the midst of a crippling ... , since 1999, the number of overdose deaths from opiate-based ... in over half a million dead from 2001 to 2015". ... oxycodone, and hydrocodone has similarly quadrupled, drawing a compelling link ...
(Date:7/12/2017)... , July 12, 2017  Eli Lilly and Company (NYSE: ... with generic companies to resolve pending patent litigation in the ... Virginia regarding the Cialis ® (tadalafil) unit ... April 26, 2020. As part of the agreement, Cialis exclusivity ... 27, 2018. "The unit dose patent for Cialis ...
(Date:7/11/2017)... SARASOTA, Fla. , July 11, 2017  Dr. Echenberg, founder of ... Dilator therapy program to patients who suffer from painful intercourse and other ... vaginismus and vaginal atrophy due to menopause. ... VuVatech LLC ... Dilators , created by Sarasota, Florida -based start-up company, ...
Breaking Medicine Technology:
(Date:7/26/2017)... Washington, DC (PRWEB) , ... July 26, 2017 ... ... Arise Infusion is pleased to now offer a major advancement in drug therapy ... their lives. Ocrevus (pronounced Ah-creh-vus) is a novel B cell targeted therapy ...
(Date:7/26/2017)... Yorba Linda, Ca (PRWEB) , ... July 26, 2017 , ... ... of optimize lyophilization processes. Inconsistent results freeze drying samples and a lengthy freeze dry ... , This webinar will discuss freeze drying techniques, as well as new accessories and ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... host its 2017 Process Validation and Process Validation Statistics Conferences in Bethesda, ... process validation lifecycle challenges faced by process validation professionals and statisticians today. ...
(Date:7/26/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of education, ... announce the 106 college athletes with type 1 diabetes who will receive scholarships as ... 1 Foundation has bestowed a total of 271 college scholarships to athletes with type ...
(Date:7/26/2017)... ... July 26, 2017 , ... IDC-Eating Disorder Care ... the treatment program located in Royal Oak, Michigan. IDC, formerly known as ... focused on providing the highest standards in the field of eating disorder treatment in ...
Breaking Medicine News(10 mins):